Skip to main content
DNA Labs India

Adrenocortical Carcinoma Symptoms: Early Detection and Genetic Insights

Genomic & Hereditary Oncology | DNA Labs India

Genomic & Hereditary Oncology

Adrenocortical Carcinoma Symptoms: Early Detection and Genetic Insights

Learn about adrenocortical carcinoma symptoms, early detection, and genetic testing. Understand hormonal signs and when to consult a doctor. DNA Labs India offers NGS-based testing.

Adrenocortical Carcinoma Symptoms: Early Detection and Genetic Insights
Adrenocortical Carcinoma Symptoms: Early Detection and Genetic Insights
PhysicianGenomic & Hereditary Oncology
Written by: Nargis SultanaMedically Reviewed by: Dr Shailaja Raghunath Murdeshwar, MBBS, MD (General Medicine)Last Updated: September 09, 2026

Adrenocortical Carcinoma Symptoms: Early Detection and Genetic Insights

At a Glance

  • Sample Required: Blood or saliva for genetic testing (if indicated)
  • Fasting Rules: No fasting required for genetic tests
  • Turnaround Time (TAT): 7–10 business days
  • Base Cost: [Insert Current 2026 Price]

Understanding Adrenocortical Carcinoma

Adrenocortical carcinoma (ACC) is a rare and aggressive cancer that arises from the adrenal cortex—the outer layer of the adrenal glands located atop each kidney. These glands produce essential hormones that regulate metabolism, blood pressure, and stress responses. ACC often presents with symptoms related to hormone overproduction or tumor mass effect. Early detection is critical for improving prognosis, as localized tumors are more amenable to surgical resection.

In India, awareness of ACC is low, but advances in diagnostic imaging and molecular testing have enhanced our ability to identify this condition at earlier stages. This article provides a comprehensive overview of ACC symptoms, diagnostic approaches, and the role of genetic testing in hereditary predisposition.

Symptoms and Clinical Presentation

Symptoms of ACC can be subtle and often mimic more common conditions. They are broadly categorized into two types: those caused by hormone excess (functional tumors) and those due to tumor growth (mass effect). The following table summarizes key symptoms and their potential hormonal associations.

SymptomDescriptionPossible Hormonal Cause
Weight gain or lossRapid, unexplained changes in body weightCortisol excess (Cushing's syndrome) or androgen excess
Muscle weaknessProximal muscle weakness, especially in thighs and shouldersCortisol-induced protein catabolism
High blood pressureHypertension resistant to standard treatmentMineralocorticoid excess (aldosterone) or cortisol
Skin changesDarkening of skin (hyperpigmentation), purple striae, easy bruisingACTH excess or cortisol
Increased hair growth (hirsutism)Facial and body hair growth in womenAndrogen excess
HeadachesPersistent, often severe headachesHypertension or mass effect
Abdominal pain or fullnessPain in the upper abdomen or flank, feeling of fullnessTumor mass effect
Mood changes or anxietyDepression, irritability, anxietyCortisol and catecholamine effects

If you experience any of these symptoms persistently for more than two weeks, it is essential to consult a healthcare provider. Early evaluation can differentiate ACC from benign adrenal adenomas or other endocrine disorders.

Diagnostic Approaches

Diagnosis of ACC typically involves a combination of imaging studies, hormonal assays, and histopathological confirmation. Imaging modalities such as CT or MRI are used to characterize adrenal masses. Hormonal workup includes measurement of cortisol, androgens, aldosterone, and catecholamines. Definitive diagnosis requires biopsy or surgical pathology.

In cases where hereditary syndromes are suspected, genetic testing plays a pivotal role. DNA Labs India offers comprehensive genomic profiling using Next-Generation Sequencing (NGS) and Whole Exome Sequencing (WES) to identify germline mutations associated with ACC, such as TP53 (Li-Fraumeni syndrome), IGF2, and CTNNB1 alterations.

Genetic Testing and Hereditary Syndromes

Approximately 5–10% of ACC cases are associated with inherited cancer predisposition syndromes. The most common include:

  • Li-Fraumeni syndrome – caused by TP53 mutations, increases risk of ACC, sarcomas, and breast cancer.
  • Beckwith-Wiedemann syndrome – associated with IGF2 overexpression, leading to pediatric ACC.
  • Lynch syndrome – due to mismatch repair gene mutations, also elevates ACC risk.

Genetic testing is recommended for individuals with a family history of these syndromes, early-onset ACC (before age 40), or multiple primary tumors. DNA Labs India's NGS-based panels provide accurate and timely results to guide surveillance and preventive strategies.

Management and Prognosis

Treatment for ACC depends on stage and resectability. Surgical resection with negative margins remains the cornerstone for localized disease. Adjuvant therapy with mitotane is often used to reduce recurrence. For advanced disease, chemotherapy and targeted therapies may be considered. Prognosis is highly variable; early-stage ACC has a 5-year survival rate of 60–80%, while metastatic disease has a poorer outlook.

Regular follow-up with imaging and hormonal markers is essential to detect recurrence early. Genetic counseling is recommended for patients with germline mutations to address family implications.

When to See a Doctor

You should seek medical attention if you experience any combination of the symptoms listed above, especially if they are new, persistent, or worsening. Additionally, if you have a known family history of ACC or related hereditary syndromes, proactive screening is advised. Early consultation can lead to timely diagnosis and better outcomes.

At DNA Labs India, we are committed to providing accurate and reliable genetic testing services. Our laboratory is ISO 9001 certified, ensuring high-quality standards in every test we perform. For more information about our ACC genetic testing panels, please contact us.

Conclusion

Adrenocortical carcinoma is a rare but serious malignancy. Awareness of its symptoms and risk factors is crucial for early detection. Advances in genetic testing have opened new avenues for identifying hereditary predisposition and guiding personalized management. If you have concerns about your adrenal health or genetic risk, do not hesitate to consult a healthcare professional and consider genetic evaluation.

💡 Key Takeaways

  • This article was written by Nargis Sultana.
  • Last updated on September 9, 2026. Clinical information is reviewed periodically.
  • Always consult with a qualified healthcare provider before making medical decisions based on the information presented here.

Need Personalized Clinical Guidance?

The information in this article is intended for educational purposes and reflects current scientific understanding. To understand how these insights apply to your specific health profile or family history, speak with a certified genetic counselor at DNA Labs India.

Medical Disclaimer: The clinical insights provided here are intended for educational purposes and do not replace professional medical advice from a primary physician. DNA Labs India is an ISO 9001:2015 certified diagnostic laboratory. Always consult with a qualified healthcare provider regarding any medical concerns, diagnoses, or treatment decisions.

Related Articles in Genomic & Hereditary Oncology

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.